This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Other. Active years: 2015.
Company Filing History:
1 out of 834,411 Years Active: 2015
Title: Hadley Mouhsine: Innovator in Pharmaceutical Treatments
Introduction
Hadley Mouhsine is a notable inventor based in Kremlin Bicetre, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of conditions linked to excessive TNF-alpha effects. Her innovative approach has led to the development of a unique compound that holds promise for medical applications.
Latest Patents
Hadley Mouhsine holds 1 patent for her invention titled "Benzenesulfon amide-compound treatment of a pathological condition linked to an excessive effect of TNF-alpha." This patent describes a benzene sulphonamide compound of formula I or one of its addition salts with pharmaceutically acceptable acids. It is intended for use in treating pathologies associated with excessive TNF-alpha effects and serves as a direct inhibitor of TNF-alpha in the human or animal body.
Career Highlights
Throughout her career, Hadley has demonstrated a strong commitment to advancing medical science. Her work has not only contributed to the understanding of TNF-alpha's role in various conditions but has also paved the way for new therapeutic strategies.
Collaborations
Hadley has collaborated with esteemed colleagues such as Jean-Francois Zagury and Matthieu Montes. These partnerships have enriched her research and expanded the impact of her innovations in the pharmaceutical field.
Conclusion
Hadley Mouhsine's contributions to pharmaceutical innovations highlight her role as a leading inventor in the treatment of TNF-alpha related conditions. Her work continues to inspire advancements in medical therapies.